What is the size of the Global Gastrointestinal Drugs Market?

The Global Gastrointestinal Drugs Market was valued at USD 44.80 billion in 2024 and will grow at a CAGR of 5.7% from 2025 to 2030. The market is expected to reach USD 59.11 billion by 2030.

What are the Global Gastrointestinal Drugs Market drivers?

Rising GI disease burden, biologics innovation, and self-medication trends are key drivers.

What are the segments under the Global Gastrointestinal Drugs Market ?

Product types include antacids, laxatives, biologics; applications include GERD, IBD, IBS.

Which is the most dominant region for the Global Gastrointestinal Drugs Market?

North America dominates with 41% share due to high disease prevalence and drug access.

Who are the leading players in the Global Gastrointestinal Drugs Market?

Takeda, AbbVie, Pfizer, J&J, Sanofi, Bayer, AstraZeneca, GSK, Bausch Health, Eisai.

Global Gastrointestinal Drugs Market | Size, Overview, Growth Trends, and Forecast

Gastrointestinal Drugs Market Research Report – Segmentation by Product Type (Antacids, Laxatives, Antidiarrheals, Anti-inflammatory Drugs, Biologics, Others), Application (Ulcerative Colitis, Crohn’s Disease, GERD, IBS, Others), and Region - Size, Share, Growth Analysis | Forecast (2025– 2030)

Published: 2025 - Jun

Report Code: VMR-18454

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

Enquire Before Buying

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.